Cibus, Inc. $CBUS

What the company doesAI summary of filing

Cibus is an agricultural biotechnology company that develops plant traits using its proprietary Rapid Trait Development System (RTDS) gene editing technology. The company licenses these traits to seed companies for royalty fees based on acres planted, with its primary focus on herbicide tolerance traits for rice targeting initial commercialization in Latin America in 2027 and the United States in 2028, representing over $200 million in estimated potential annual royalties. The company also develops sustainable ingredients including biofragrance products through a partnership with Procter & Gamble and opportunistically pursues partner-funded trait development in crops such as canola and soybean. Cibus is a revenue-generating stage company pursuing commercialization of its initial trait products. [10-K 2026-03-17]

Segments: Rice herbicide tolerance traits, Canola traits (pod shatter reduction, weed management, sclerotinia resistance), Sustainable ingredients and biofragrances, Soybean traits